Application of Supervised Machine Learning Models for Drug-Action Prediction Towards Nuclear Type I Receptors
Jaundoo, R.; Tuszynski, J. A.; Craddock, T. J. A.
Show abstract
1.Interactions between drugs can lead to adverse side effects for patients taking combination therapies to treat complex diseases such as cancer. Knowledge of drug-action towards a receptor would allow these drug-drug interactions to be predicted, and in this study, we trained a total of 5 different machine learning models to classify whether a given drug was an agonist (activator), antagonist (blocker), or a decoy (non-binder) to each of the androgen, estrogen, glucocorticoid, and progesterone receptors. The classification performance and efficiency, measured in training time, of the decision tree, naive Bayes, neural network, random forest, and support vector machine models for each receptor were then compared. The results showed that the decision tree and naive Bayes models were best suited for drug-action prediction across all receptors while only requiring minutes of training time at most. Future work will focus on increasing the prediction accuracy of antagonist drugs, integrating experimental data during training, and using other targets outside of nuclear type I receptors.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors 93%
- Chemical Genomics Language Model toward Reliable and Explainable Compound-Protein Interaction Exploration 93%
- PDBe CCDUtils: an RDKit-based toolkit for handling and analysing small molecules in the Protein Data Bank 93%
Similar papers in this journal
- Retro Drug Design: From Target Properties to Molecular Structures 96%
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 94%
- Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction 94%
Similar papers in this journal
- PharmaNet: Pharmaceutical discovery with deep recurrent neural networks. 94%
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 94%
- TargetDB: A target information aggregation tool and tractability predictor 93%
Similar papers in this journal
Similar papers in this journal
- DrugForm-DTA: Towards real-world drug-target binding Affinity Model 94%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 94%
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.